Standard Biotools (LAB) Preferred Shares Issued (2022)
Standard Biotools (LAB) reported Preferred Shares Issued of $202.7 million for Q2 2022.
Standard Biotools (LAB) has 1 years of Preferred Shares Issued data on file, last reported at $202.7 million in Q2 2022.
- Quarterly Preferred Shares Issued changed N/A year-over-year to $202.7 million in Q2 2022, while the trailing twelve-month figure through Sep 2023 was $202.7 million (changed 0.0% YoY) and the FY2022 annual result came in at $225.0 million, changed N/A from the prior year.
- Preferred Shares Issued was little changed at $202.7 million in Q2 2022 per LAB's latest filing.
- Across five years, Preferred Shares Issued topped out at $202.7 million in Q2 2022 and bottomed at $202.7 million in Q2 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | - |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | - |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Standard Biotools | 448.37 Mn | -6.80 Mn | 11.31 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | 202.70 Mn |
| Jun 30, 2022 | 202.70 Mn |